Does SILTUXIMAB Cause Pulmonary embolism? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Pulmonary embolism have been filed in association with SILTUXIMAB (Sylvant). This represents 1.5% of all adverse event reports for SILTUXIMAB.
7
Reports of Pulmonary embolism with SILTUXIMAB
1.5%
of all SILTUXIMAB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Pulmonary embolism From SILTUXIMAB?
Of the 7 reports, 1 (14.3%) resulted in death.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SILTUXIMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does SILTUXIMAB Cause?
Off label use (96)
Drug ineffective (72)
Disease progression (32)
Immune effector cell-associated neurotoxicity syndrome (28)
Death (27)
Cytokine release syndrome (26)
Hypertension (24)
Product use in unapproved indication (24)
Drug effective for unapproved indication (23)
Cataract (19)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which SILTUXIMAB Alternatives Have Lower Pulmonary embolism Risk?
SILTUXIMAB vs SILVER SULFADIAZINE
SILTUXIMAB vs SIMEPREVIR
SILTUXIMAB vs SIMPONI
SILTUXIMAB vs SIMVASTATIN
SILTUXIMAB vs SINGULAIR